American Oncology Network, Inc. (AONC)
OTCMKTS
· Delayed Price · Currency is USD
3.110
0.00 (0.00%)
Oct 31, 2024, 11:33 AM EDT
American Oncology Network Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | 1.83 | -5.54 | 2.59 | -0.11 | 21.95 | 2.77 |
Depreciation & Amortization | 17.34 | 16.74 | 17.08 | 6.08 | 3.66 | 1.01 |
Other Amortization | 0.86 | 0.79 | 0.63 | 0.36 | 0.02 | 0.03 |
Loss (Gain) From Sale of Assets | 0.47 | -0.29 | -0.12 | -0.08 | - | - |
Loss (Gain) on Equity Investments | 0.17 | 0.26 | - | - | - | - |
Stock-Based Compensation | 16.27 | 4.87 | - | 0.02 | 0.02 | 0.02 |
Other Operating Activities | -76.96 | -47.02 | - | 2.16 | -0.53 | 0.37 |
Change in Accounts Receivable | 19.74 | 6.95 | -24.87 | -30.8 | -35.49 | -29.78 |
Change in Inventory | -9.92 | -8.09 | -1.95 | -10.26 | -6.27 | -3.86 |
Change in Accounts Payable | 65.36 | 20.07 | 14.08 | 21.68 | 34 | 15.46 |
Change in Other Net Operating Assets | -39.81 | -6.85 | -14.22 | -15.39 | 19.88 | -4.32 |
Operating Cash Flow | -4.64 | -18.12 | -6.78 | -26.34 | 37.25 | -18.3 |
Capital Expenditures | -13.56 | -12.28 | -7.19 | -8.32 | -12.22 | -11.62 |
Sale of Property, Plant & Equipment | 0.84 | 0.7 | 2.08 | 0.68 | - | - |
Cash Acquisitions | -6.71 | - | -0.01 | -3.22 | -0.93 | -3.81 |
Investment in Securities | -10.78 | -25.08 | -9.97 | - | - | - |
Other Investing Activities | 0.8 | 1.12 | 1.09 | 0.16 | -1.52 | -5.78 |
Investing Cash Flow | -29.42 | -35.53 | -13.99 | -10.69 | -14.67 | -21.21 |
Short-Term Debt Issued | - | - | - | - | - | 31.26 |
Long-Term Debt Issued | - | - | 16.25 | 65 | 12.52 | 27.01 |
Total Debt Issued | - | - | 16.25 | 65 | 12.52 | 58.27 |
Short-Term Debt Repaid | - | - | - | - | - | -11.69 |
Long-Term Debt Repaid | - | -0.59 | -0.43 | -37.3 | -24.58 | -7.31 |
Total Debt Repaid | -2.47 | -0.59 | -0.43 | -37.3 | -24.58 | -19 |
Net Debt Issued (Repaid) | -2.47 | -0.59 | 15.82 | 27.7 | -12.07 | 39.27 |
Issuance of Common Stock | - | - | - | - | 28.5 | - |
Repurchase of Common Stock | -3.72 | -0.09 | - | - | - | - |
Preferred Dividends Paid | -1.31 | -9.48 | - | - | - | - |
Dividends Paid | -1.31 | -9.48 | - | - | - | - |
Other Financing Activities | 2.66 | 0.43 | -0.48 | -1.15 | -0.18 | -0.09 |
Financing Cash Flow | -4.84 | 55.27 | 15.35 | 26.54 | 16.26 | 39.18 |
Net Cash Flow | -38.89 | 1.61 | -5.43 | -10.49 | 38.83 | -0.33 |
Free Cash Flow | -18.2 | -30.4 | -13.98 | -34.66 | 25.02 | -29.91 |
Free Cash Flow Margin | -1.25% | -2.38% | -1.22% | -3.67% | 3.45% | -9.35% |
Free Cash Flow Per Share | -1.59 | -4.55 | - | - | - | - |
Cash Interest Paid | 5.85 | 5.85 | 2.18 | 1.38 | 1.1 | 1.1 |
Cash Income Tax Paid | - | - | - | 0.58 | 0.34 | 0 |
Levered Free Cash Flow | 32.74 | 19.11 | 1.58 | -44.06 | - | - |
Unlevered Free Cash Flow | 36.28 | 22.33 | 3.09 | -43.53 | - | - |
Change in Net Working Capital | -38.26 | -21.2 | 12.33 | 41.88 | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.